Zuxing Kan

1.5k citations
33 papers · 1.2k indexed · h-index 22
Topics
Hepatocellular Carcinoma Treatment and Prognosis (16 papers)Liver physiology and pathology (7 papers)Liver Disease Diagnosis and Treatment (7 papers)

In The Last Decade

Zuxing Kan

33 papers receiving 1.2k citations

Peers

Zuxing Kan
Comparison fields: 5 of 84
  • Hepatology 656
  • Epidemiology 313
  • Surgery 303
  • Radiology, Nuclear Medicine and Imaging 276
  • Pulmonary and Respiratory Medicine 196
Replace Josephina A. Vossen with:
Josephina A. Vossen United States
Thomas J. Vogl Germany
Takamichi Ishii Japan
Suzette Walker United States
Spyros Rizos Greece
Warner Prevoo Netherlands
Satoshi Ogiso Japan
Ruhai Zou China
Antonia Digklia Switzerland
Hui-Hong Liang China
Zuxing Kan relative to Josephina A. Vossen United States Josephina A. Vossen's profile →
Citations per field
00.5×1.6×
Josephina A. Vossen · 1×
Citations per year

Countries citing papers authored by Zuxing Kan

Since Specialization
Citations

This map shows the geographic impact of Zuxing Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuxing Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuxing Kan more than expected).

Fields of papers citing papers by Zuxing Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuxing Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuxing Kan. The network helps show where Zuxing Kan may publish in the future.

Co-authorship network of co-authors of Zuxing Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Zuxing Kan. A scholar is included among the top collaborators of Zuxing Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuxing Kan. Zuxing Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 21
2 6
3 42
4 30
5 95
6 32
7 24
8 3
9 32
10 4
11 4
12 8
13 4
14 3
15 36
16 26
17 74
18 74
19 39
20 8

About Zuxing Kan

Zuxing Kan is a scholar working on Hepatology, Cancer Research and Biotechnology, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Liver physiology and pathology (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Hepatology (656 citations), Cancer Research (190 citations) and Radiology, Nuclear Medicine and Imaging (276 citations). Zuxing Kan has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Sidney Wallace, Anders Lunderquist, Chusilp Charnsangavej, Sith Phongkitkarun, Satoshi Kobayashi, Kenneth C. Wright, Patricia A. McCuskey, Krassi Ivancev, David C. Madoff and S Wallace. Their work appears in journals such as Hepatology, Radiology and Journal of Biomedical Materials Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026